$1.840
+0.062 (+3.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GRCE por análisis de gráficos similares
Alphio's GRCE stock price prediction model matches the current Grace Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.75 (-5.12%). The 1-week path is $1.84 (+0.19%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Grace Therapeutics, Inc?
Grace Therapeutics, Inc. (GRCE) is currently priced at $1.81, which is significantly below its 52-week high of $5.18, indicating potential upside. However, the stock has a low RSI of 34.73, suggesting it may be oversold, but the recent FDA rejection and a net loss of $7.8 million for FY 2026 raise concerns about its near-term recovery. Given these factors, it is advisable to hold the stock for now while monitoring developments.
GRCE cerró en $1.84 el Friday, tras subir +3.37%
Grace Therapeutics, Inc (GRCE) last closed at $1.84, gaining +3.37%. These facts feed the 1-day and 1-week GRCE price prediction above.
Factores de la previsión
Los factores de la previsión de Grace Therapeutics, Inc (GRCE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GRCE, ordenadas por similitud.
Análisis de estacionalidad de GRCE
Historically the probability of a positive November return for GRCE is 45.45%. March offers the highest probability of a positive month at 66.67%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GRCE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $3.02 | $3.33 | $3.80 | +80.76% |
| Dec 2026 | $2.55 | $3.00 | $3.03 | +62.98% |
En 2026, se proyecta que Grace Therapeutics, Inc (GRCE) oscile entre $2.55 y $3.80.
Previsión mensual de Grace Therapeutics, Inc para 2026
En Nov de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.33, con un mínimo de $3.02 y un máximo de $3.80.
En Dec de 2026, se proyecta que Grace Therapeutics, Inc promedie $3.00, con un mínimo de $2.55 y un máximo de $3.03.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.